CME | Stimulants & Strategy: Integrating ADHD Treatments Into Daily Practice
Release Date: 11/03/2025
Inside Family Medicine
In this episode of Inside Family Medicine, we hear from Dr. Brittney Anderson, a board-certified family physician and founder of Anderson Family Care in rural Alabama. Dr. Anderson discusses her journey from training to opening her private practice, the importance of providing comprehensive care in rural areas, and the challenges and rewards of owning a private practice. She emphasizes the significance of community involvement and shares valuable advice for physicians considering opening their own practices. Topics By Timestamp 00:00 Introduction 00:11...
info_outlineInside Family Medicine
In this episode of CME on the Go, our hosts delve into the nuances of medical teaching and education. They share personal experiences, teaching strategies, and the significance of engaging learners from different generations. The episode highlights the importance of questioning, respect, and collaborative learning in developing skilled family physicians. Special guest, Chief Resident Elaine Wong, provides insights into what makes teaching effective from a learner’s perspective, emphasizing the value of interactive and respectful learning environments. After listening to the...
info_outlineInside Family Medicine
In this episode of Fighting for Family Medicine, host David Tully, vice president of Government Relations at the AAFP, speaks with Kate Gilliard, the Academy’s senior manager for federal policy and regulatory affairs, about the newly finalized 2026 Medicare physician fee schedule (MPFS). The conversation covers the MPFS’ efficiency adjustment policy, adjustments for practice expense and the creation of new add-on codes for advanced primary care management (APCM) services. Topics By Timestamp 00:00 Introduction 00:24 Breaking down the 2026 Medicare...
info_outlineInside Family Medicine
In this special edition of ‘Inside Family Medicine’, sponsored by Sanofi, Dr. Jana Shaw and Dr. Peter Ziemkowski discuss potential changes to the meningococcal vaccination schedule. Key topics include the current two-dose vaccination schedule, proposed alternative schedules, recent research findings, and the potential implications of schedule changes on public health, health equity, and disease prevention. The episode emphasizes the importance of maintaining the current vaccination schedule for effective disease prevention and highlights the significance of timely vaccinations in...
info_outlineInside Family Medicine
In this episode of CME on the go, recorded live at FMX in Anaheim, our hosts discuss the complexities of ADHD treatment. They cover initial thoughts on stimulant and non-stimulant medications, dosing guidelines, and the importance of addressing comorbid conditions. Listeners' feedback from a previous ADHD episode is highlighted, emphasizing the need for practical prescribing insights. The hosts also discuss the relevance of shared decision-making and strategies for managing ADHD amid potential substance abuse risks. After listening to the podcast episode, claim 0.5 AAFP...
info_outlineInside Family Medicine
In this episode, AAFP Vice President of Government Relations David Tully recaps the Academy’s October advocacy efforts around vaccines, workforce and immigration. Topics by Timestamp 00:37 Addressing the IMG Visa Issue 02:07 Advocating for the Safe Step Act 02:56 Impact of Government Shutdown on Healthcare 03:58 Combating Vaccine Misinformation 04:42 Celebrating New Leadership 05:34 Conclusion and Call to Action Additional Resources October 2025 FMAR ...
info_outlineInside Family Medicine
In this episode of Fighting for Family Medicine, David Tully, AAFP vice president of Government Relations, speaks with Herb Conaway, MD, JD, a physician and congressman representing New Jersey's Third Congressional District. They discuss the intersection of health care and policymaking, the significance of physician advocacy and the impacts of recent legislative decisions on Medicaid and Medicare. Dr. Conaway shares insights on promoting evidence-based practices amid political challenges and emphasizes the essential role physicians play in both health care and politics. ...
info_outlineInside Family Medicine
In this episode of CME on the Go, our hosts discuss retirement planning for family physicians. They cover insights tailored for different career stages, from early financial planning for students and residents to finding fulfilling post-retirement activities for mid-to-late career doctors. They also delve into the importance of maintaining joy in practice, setting up sustainable boundaries, and exploring financial literacy, all while preparing for a balanced and fulfilling retirement. After listening to the podcast episode, claim 0.5 AAFP credit by following the...
info_outlineInside Family Medicine
In this episode of Inside Family Medicine, we speak with Karen Johnson, Vice President of Practice Advancement at AAFP, and Drs. Brent Sugimoto and Jennifer Pena. The discussion focuses on the integration of AI in primary care, addressing AI's potential to alleviate administrative burdens, enhance patient care, and improve clinician workflows. The guests share personal experiences, challenges, and the future outlook for AI in health care, emphasizing the need for clinician involvement in AI development and the importance of building trust and transparency between technology developers and...
info_outlineInside Family Medicine
In this episode of CME on the Go, our hosts delve into the complex domain of women's health with a particular focus on abnormal uterine bleeding and polycystic ovarian syndrome (PCOS). They begin by addressing various causes of abnormal uterine bleeding and the diagnostic criteria and treatment approaches for PCOS. Topics include the underutilized methodology for diagnosing PCOS, the controversial use of metformin, the efficacy of hormonal treatments, and the evolving research on the condition. The episode emphasizes the importance of listening to patients and addressing their concerns to...
info_outlineIn this episode of CME on the go, recorded live at FMX in Anaheim, our hosts discuss the complexities of ADHD treatment. They cover initial thoughts on stimulant and non-stimulant medications, dosing guidelines, and the importance of addressing comorbid conditions. Listeners' feedback from a previous ADHD episode is highlighted, emphasizing the need for practical prescribing insights. The hosts also discuss the relevance of shared decision-making and strategies for managing ADHD amid potential substance abuse risks.
After listening to the podcast episode, claim 0.5 AAFP credit by following the provided link.
Learning Objectives
- Design efficient workflows for managing controlled substances in ADHD treatment, balancing regulatory requirements with patient care.
- Analyze the pharmacology, clinical applications, and abuse potential of stimulant medications, including considerations for off-label use and misuse in non-ADHD populations.
- Integrate ADHD medications into treatment plans for patients with comorbid psychiatric conditions, such as depression, to enhance overall therapeutic outcomes.
References and Resources
Chang Z, Lichtenstein P, Halldner L, et al. Stimulant ADHD medication and risk for substance abuse. J Child Psychol Psychiatry. 2014;55(8):878-885. doi:10.1111/jcpp.12164
Volkow ND, Swanson JM. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?. Am J Psychiatry. 2008;165(5):553-555. doi:10.1176/appi.ajp.2008.08020237
Published Online: 17 May 2022
The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders
Authors: Timothy E. Wilens https://orcid.org/0000-0002-5749-8503 twilens@mgh.harvard.edu, Diana W. Woodward, Je Deuk Ko, Amy F. Berger, Colin Burke, and Amy M. Yule
Molina BSG, Kennedy TM, Howard AL, et al. Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood. JAMA Psychiatry. 2023;80(9):933-941. doi:10.1001/jamapsychiatry.2023.2157
Olagunju AE, Ghoddusi F. Attention-Deficit/Hyperactivity Disorder in Adults. Am Fam Physician. 2024;110(2):157-166.
Attention-Deficit/Hyperactivity Disorder Medications for Adults: Drugs [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Nov. Available from: https://www.ncbi.nlm.nih.gov/books/NBK610422/
Disclosure: It is the policy of the AAFP that all individuals in a position to control content disclose any relationships with commercial interests upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflicts of interest and, if identified, conflicts are resolved prior to confirmation of participation. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this CME activity. All individuals in a position to control content for this session have indicated they have no relevant financial relationships to disclose.
Disclaimer: Copyright 2025. AAFP. The views presented in this broadcast are the speaker’s own and do not represent those of AAFP. The information presented is for general, educational, or entertainment purposes and should not be considered legal, health, financial, or other advice. AAFP makes no representation as to the accuracy or completeness of the information and is not responsible for results that may arise from its use. Consult an appropriate professional concerning your specific situation and respective governing bodies for applicable laws. Reference to any specific product or entity does not constitute an endorsement or recommendation by AAFP unless specifically stated otherwise. AAFP and the AAFP logo are registered trademarks of American Academy of Family Physicians.